These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 36432183)

  • 1. An Overview of Antitumour Activity of Polysaccharides.
    Jin H; Li M; Tian F; Yu F; Zhao W
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysaccharide-based nanomedicines for cancer immunotherapy: A review.
    Zeng Y; Xiang Y; Sheng R; Tomás H; Rodrigues J; Gu Z; Zhang H; Gong Q; Luo K
    Bioact Mater; 2021 Oct; 6(10):3358-3382. PubMed ID: 33817416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Anionic Polysaccharides in the Preparation of Nanomedicines with Anticancer Applications.
    Martínez AM; Benito M; Pérez E; María Teijón J; Dolores Blanco M
    Curr Pharm Des; 2016; 22(22):3364-79. PubMed ID: 26818877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges.
    Jiang Y; Yan C; Li M; Chen S; Chen Z; Yang L; Luo K
    Int J Biol Macromol; 2024 Oct; 278(Pt 4):135072. PubMed ID: 39191341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Polysaccharides Mimetic Components in Targeted Cancer Treatment.
    Gupta N; Malviya R
    Curr Drug Targets; 2022; 23(9):856-868. PubMed ID: 35156570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy.
    Li Q; Liu X; Yan C; Zhao B; Zhao Y; Yang L; Shi M; Yu H; Li X; Luo K
    Small; 2023 Jun; 19(23):e2206211. PubMed ID: 36890780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production, purification and characterisation of polysaccharides from Pleurotus ostreatus with antitumour activity.
    Silva S; Martins S; Karmali A; Rosa E
    J Sci Food Agric; 2012 Jul; 92(9):1826-32. PubMed ID: 22234986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
    Ranjbari J; Mokhtarzadeh A; Alibakhshi A; Tabarzad M; Hejazi M; Ramezani M
    Curr Pharm Des; 2018 Feb; 23(39):6019-6032. PubMed ID: 28482782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysaccharides based nanomaterials for targeted anti-cancer drug delivery.
    Dheer D; Arora D; Jaglan S; Rawal RK; Shankar R
    J Drug Target; 2017 Jan; 25(1):1-16. PubMed ID: 27030377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural polysaccharides and their derivatives targeting the tumor microenvironment: A review.
    Wang W; Zhao B; Zhang Z; Kikuchi T; Li W; Jantrawut P; Feng F; Liu F; Zhang J
    Int J Biol Macromol; 2024 May; 268(Pt 2):131789. PubMed ID: 38677708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysaccharide Nanoparticles for Targeted Cancer Therapies.
    Peng P; Yang K; Tong G; Ma L
    Curr Drug Metab; 2018; 19(9):781-792. PubMed ID: 29749308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer polysaccharides from natural resources: a review of recent research.
    Zong A; Cao H; Wang F
    Carbohydr Polym; 2012 Nov; 90(4):1395-410. PubMed ID: 22944395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on advances in graphene-derivative/polysaccharide bionanocomposites: Therapeutics, pharmacogenomics and toxicity.
    Makvandi P; Ghomi M; Ashrafizadeh M; Tafazoli A; Agarwal T; Delfi M; Akhtari J; Zare EN; Padil VVT; Zarrabi A; Pourreza N; Miltyk W; Maiti TK
    Carbohydr Polym; 2020 Dec; 250():116952. PubMed ID: 33049857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemically Modified Natural Polymer-Based Theranostic Nanomedicines: Are They the Golden Gate toward a
    Jaymand M
    ACS Biomater Sci Eng; 2020 Jan; 6(1):134-166. PubMed ID: 33463213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy.
    Yang K; Yang Z; Yu G; Nie Z; Wang R; Chen X
    Adv Mater; 2022 Feb; 34(6):e2107434. PubMed ID: 34693571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine for increasing the oral bioavailability of cancer treatments.
    Parodi A; Buzaeva P; Nigovora D; Baldin A; Kostyushev D; Chulanov V; Savvateeva LV; Zamyatnin AA
    J Nanobiotechnology; 2021 Oct; 19(1):354. PubMed ID: 34717658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review.
    Yu Y; Shen M; Song Q; Xie J
    Carbohydr Polym; 2018 Mar; 183():91-101. PubMed ID: 29352896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modifications of polysaccharides and their anti-tumor activities.
    Xie L; Shen M; Hong Y; Ye H; Huang L; Xie J
    Carbohydr Polym; 2020 Feb; 229():115436. PubMed ID: 31826393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activity of seaweeds.
    Gutiérrez-Rodríguez AG; Juárez-Portilla C; Olivares-Bañuelos T; Zepeda RC
    Drug Discov Today; 2018 Feb; 23(2):434-447. PubMed ID: 29107095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revolutionizing cancer treatment: Harnessing the power of terrestrial microbial polysaccharides.
    Ju H; Liu Y; Gong J; Gong PX; Wang ZX; Wu YC; Li HJ
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133171. PubMed ID: 38880444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.